company

OCTAPHARMA AS

2069 JESSHEIM

Return on Equity
13,86 %
Current Ratio
2,55
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue429 026 000
Net Income10 880 000
Total Assets129 112 000
Total Equity78 487 000
Income (NOK)2022
Revenue429 026 000
Expenditure415 080 000
Operating Profit13 946 000
Financial Income8 000
Financial Costs4 000
Financial Balance4 000
Earnings Before Tax13 950 000
Tax3 069 000
Net Income10 880 000
Balance (NOK)2022
Total Fixed Assets85 000
Total Current Assets129 027 000
Total Assets129 112 000
Total Retained Equity78 337 000
Total Equity78 487 000
Total Long-Term Debt0
Total Current Debt50 625 000
Total Equity and Debt129 112 000
Cash flow (NOK)2022
Sales Income429 019 000
Other Income7 000
Revenue429 026 000
Cost of Goods Sold408 898 000
Salary Costs4 139 000
Depreciation27 000
Impairment0
Expenditure415 080 000
Operating Profit13 946 000
Financial Income8 000
Financial Costs4 000
Financial Balance4 000
Dividends0
Net Income10 880 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets6 000
Real Eastate0
Machinery and Plant Facilities43 000
Fixtures37 000
Total Tangible Assets80 000
Total Fiancial Fixed Assets0
Total Fixed Assets85 000
Stock17 642 000
Total Investments0
Cash, Bank22 636 000
Total Current Assets129 027 000
Total Assets129 112 000
Total Equity78 487 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors26 839 000
Unpaid Taxes18 731 000
Dividends0
Other Current Debt2 003 000
Total Current Debt50 625 000
Total Equity and Debt129 112 000
Financial indicators2022
Return on Equity13,86 %
Debt-to-Equity Ratio0
Operating Profit Margin3,25 %
Current Ratio2,55
Quick Ratio3,91
Equity Ratio0,61
Gross Profit Margin4,69 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English